Indian Pharmaceutical Alliance Calls for a Stronger U.S.India Partnership for Affordable Medicine businesswireindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswireindia.com Daily Mail and Mail on Sunday newspapers.
Indian Pharmaceutical Alliance Calls for a Stronger U.S.-India Partnership for Affordable Medicine aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its drugs in North America.
/PRNewswire/ The global motion sickness drugs market size is estimated to grow by USD 136.49 million from 2023 to 2027, according to Technavio. This growth.